Modeling Chagas disease in Chile: From vector to congenital transmission

Mauricio Canals1, Dante Cáceres2, Sergio Alvarado2

  • 1Programa de Salud Ambiental, Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Chile; Departamento de Medicina, Facultad de Medicina, Universidad de Chile, Chile.

Bio Systems
|April 25, 2017
PubMed

Insights

Chagas disease dynamics were modeled, revealing vector transmission is key to eradication. Interrupting domestic transmission and controlling wild vectors are crucial for eliminating Chagas disease.

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Chagas disease is a significant public health issue in Latin America, particularly in northern Chile.
  • Vector transmission of Chagas disease was interrupted in 1999 with the elimination of Triatoma infestans.
  • The epidemiologic dynamics of Chagas disease require updated modeling following vector control efforts.

Purpose of the Study:

  • To model the dynamics of Chagas disease incorporating both vector and congenital transmission.
  • To analyze the contributions of vector and congenital transmission to the overall disease burden.
  • To identify key parameters influencing Chagas disease transmission and eradication.

Main Methods:

  • Development of a mathematical model integrating vector and congenital transmission pathways.
  • Simulation of disease dynamics based on the proposed model.
  • Derivation and analysis of the basic reproductive number (R0) and sensitivity analyses.

Main Results:

  • The basic reproductive number (R0) is a sum of vector (R0V) and congenital (R0C) contributions, with R0V being dominant.
  • Chagas disease transmission declines exponentially within 2-3 generations if vector transmission is eliminated.
  • Human bite rate, vector density, and insect vector mortality are critical parameters.

Conclusions:

  • Interruption of domestic vector transmission is essential for Chagas disease eradication.
  • Post-eradication strategies must focus on preventing wild vector domiciliation and re-infestation.
  • Adequate treatment coverage for congenital Chagas disease cases is vital.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...